Study participant of the SYNERGIC Trial completing cognitive exercises

Peter Saracino is currently taking part in the SYNERGIC Trial led by Dr. Manuel Montero-Odasso. The study includes cognitive training and physical exercises with the hopes of delaying dementia. 

London researchers receive almost $1.35 million to continue groundbreaking dementia research 

St. Joseph’s: Parkwood Institute - 

Researchers in London, Ontario have been awarded $1.345 million over five years through the second phase of the Canadian Consortium on Neurodegeneration in Aging (CCNA), announced today as part of Canada’s first national dementia strategy. CCNA is a collaborative research program tackling the challenge of dementia and other neurodegenerative illnesses. 

Two new studies on Alzheimer’s disease currently recruiting participants

St. Joseph’s: Parkwood Institute - 

Two new interventional studies have been brought to London, focused on improving quality of life for patients with Alzheimer’s disease and their caregivers. Both hope to improve upon standard approaches to treating agitation, a core symptom of Alzheimer’s.

Agitation is a significant source of stress for patients and caregivers. It is complex and difficult to treat. Often, families do not know about this particular symptom of Alzheimer’s and are not properly trained on how to manage care while dealing with agitation. 

Laura Craven, PhD candidate, recognized for her leadership, clinical research and community involvement

Off­site - 

Laura Craven was presented with the Leadership Award for Fellows and Students at this year’s Lawson Impact Awards on April 11. This award recognizes individuals who demonstrate exceptional leadership qualities, strong research skills, and dedication to the advancement of health research.

Pages